HOME

Sanger Sequencing

GATC Biotech has its roots deep in the field of Sanger sequencing. Founded in 1990, the company commercialised the first nonradioactive sequencing technology platform, Direct-Blotting-Electrophoresis-System GATC 1500.

NextGen Sequencing

Genomic innovation – Made in Germany
GATC Biotech offers all leading sequencing technologies in its own laboratories. The company’s proprietary workflows deliver high-quality results backed by ISO 17025 accreditation and ISO 13485 certification.

GATCLIQUID

The X-ray of the 21^st century
Our liquid biopsy-based service line offers cancer characterisation from a simple blood sample.

MYCOPLASMACHECK

Reliable and sensitive service for the detection of all relevant mycoplasma contaminations for close quality control of cell cultures.

Liquid biopsy in cancer research

GATC Biotech is the first service provider to offer access to liquid biopsy-based assays with unprecedented flexibility for any stage or any project of blood-based tumour characterisation. Learn more now.

Trust your peers

Platinum SelectScience® Seal of Quality underlines the excellence of GATC Biotech’s LIGHTRUN and SUPREMERUN Sanger sequencing.

Why GATC Biotech

GATC Biotech, a family- owned business since 1990, is Europe’s leading sequencing services provider with more than 10,000 customers from academia, healthcare and industry worldwide.

Featured events:

September 21

Actualites en oncologie - Journees de la Societe Francaise du Cancer

Paris, France | September 21

Actualites en oncologie - Journees de la Societe Francaise du Cancer

GATC Biotech’s Sanger sequencing services receive Platinum Seal of Quality from SelectScience

Constance, Germany, June 29, 2017: GATC Biotech, Europe’s leading sequencing service provider, was pleased to receive the platinum SelectScience® Seal of Quality for its two Sanger sequencing services, SUPREMERUN and LIGHTRUN for the year 2017. The...

GATC to be part of Eurofins Group

Constance, Germany, June 2nd, 2017: GATC, one of the leading sequencing provider will be a part of the Eurofins Group as of July 2017 to create the leading company in the worldwide sequencing market.Eurofins Scientific (EUFI.PA), a global leader in...